These data and the information that increased conversion of Gln to Glu has been described in glioma cells harboring IDH1 mutation [41] motivated us to investigate the IDH1 mutation status influence in the expression levels of genes involved in the glutaminolysis pathway and GSH. This evidence concerns the gene IDH1 and glioma.